Screening and Secondary Prevention Rheumatic Heart Disease Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Screening and Secondary Prevention Rheumatic Heart Disease Study — Stella

Home/Rheumatic Heart Disease/

View on ClinicalTrials.gov

Recruiting

Back to Rheumatic Heart Disease trials

Trial locations(1 site)

Pakistan

National Institute of Cardiovascular Diseases (NICVD), Karachi, Sindh

Key details

Sponsor

National Institute of Cardiovascular Diseases, Pakistan

Enrollment target

~5,000 participants

Started

September 2022

Primary completion

December 2028

Age range

10 Years – 30 Years

Last updated August 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.